Wells Fargo Maintains Overweight on Axogen, Raises Price Target to $56

Benzinga · 2d ago
Wells Fargo analyst Larry Biegelsen maintains Axogen (NASDAQ:AXGN) with a Overweight and raises the price target from $48 to $56.